Add this topic to your myFT Digest for news straight to your inbox
Prison term exceeds that handed to former business partner Elizabeth Holmes of failed blood-testing start-up
Judge’s decision caps blood-testing company saga that put a spotlight on Silicon Valley start-up culture
Elizabeth Holmes’s ex-partner was accused of misleading outsiders about blood testing start-up
Supporters worry spirit of entrepreneurship in ‘jeopardy’ while others say she overstepped boundaries
Elizabeth Holmes lied and doctored documents when her technology fell short
A proposition that seems too good to be true generally will be
Founder of blood testing start-up Theranos convicted on four charges including defrauding investors
Blood testing start-up’s founder pushed back against allegations she deliberately misled investors
Founder of blood testing start-up denies trying to intimidate journalist who exposed company’s flaws
Founder of blood-testing company testifies Ramesh Balwani berated her and forced her to have sex
Chief executive of defunct healthcare start-up tries to pre-empt prosecutors’ questions — but the true test is yet to come
Defence made surprise move to put founder on stand in case that focuses on Silicon Valley culture
Lawyers offer conflicting narratives on whether Theranos founder misled investors
Lawyers say Elizabeth Holmes’s failure to make Theranos a viable business was not a crime
Prosecution and defence clash over Elizabeth Holmes’s intentions during opening arguments in criminal case
Investors have poured more than $200m into developing a small device in the past year alone
A fresh push on fast and reliable Covid diagnostics is needed to supplement the vaccine effect
EU drafts plan to avoid repeat of 2015 refugee crisis
Holmes accused of defrauding investors and patients by making false claims about blood tests
Silencing agreements can stop important information on fraud or mistreatment from reaching the public
John Carreyrou, winner of the FT/McKinsey Business Book Award, talks about Bad Blood
John Carreyrou takes the prize for his riveting account of the collapse of Theranos
FT columnists explore the titles shortlisted for the FT/McKinsey award
The upcoming fights between unicorn investors will be brutal
International Edition